Yip, S., Rahit, K. M. T. H., Gibson, A. W., Xu, T. J., Parpalli, V., Dean, M. L., Heng, D. Y. C., Alimohamed, N. S., Ruether, J. D., Navani, V., Lee-Ying, R. M., Amuda-James, O., Ohland, C., McCoy, K., Bose, P. (2026). Gut microbiome (GMB) biomarkers in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair alterations (HRRm) treated with PARP inhibitor (PARPi) therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.248